Evidence map›Paper›PMID 30261054›Full record

ArticlePloS one2018

Identification of putative effectors of the Type IV secretion system from the Wolbachia endosymbiont of Brugia malayi.

Emily M Carpinone, Zhiru Li, Michael K Mills, Clemence Foltz, Emma R Brannon, Clotilde K S Carlow, Vincent J Starai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Three feminizingFrontiers in microbiology · 2024
    Article
  6. The cellular lives of Wolbachia.Nature reviews. Microbiology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Restriction ofmBio · 2022
    Article
  11. Microbial genomics · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. TheMicrobiology spectrum · 2019
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Emily M CarpinoneDepartment of Microbiology, University of Georgia, Athens, GA, United States of America.
Zhiru LiDivision of Genome Biology, New England Biolabs, Ipswich, MA, United States of America.
Michael K MillsDepartment of Microbiology, University of Georgia, Athens, GA, United States of America.
Clemence FoltzDivision of Genome Biology, New England Biolabs, Ipswich, MA, United States of America.
Emma R BrannonDepartment of Microbiology, University of Georgia, Athens, GA, United States of America.
Clotilde K S CarlowDivision of Genome Biology, New England Biolabs, Ipswich, MA, United States of America.
Vincent J StaraiDepartment of Microbiology, University of Georgia, Athens, GA, United States of America.ORCID 0000-0003-2415-412X
University of Georgia · USNew England Biolabs (United States) · US

Funding

Bacterial inhibitors of eukaryotic membrane fusionR01AI100913 · NIAID · UNIVERSITY OF GEORGIA · PI STARAI, VINCENT JOSEPH · 2013 to 2017
$1.7M
NIAID NIH HHS R01 AI100913
6 · The paper itself

Abstract

Wolbachia is an unculturable, intracellular bacterium that persists within an extremely broad range of arthropod and parasitic nematode hosts, where it is transmitted maternally to offspring via vertical transmission. In the filarial nematode Brugia malayi, a causative agent of human lymphatic filariasis, Wolbachia is an endosymbiont, and its presence is essential for proper nematode development, survival, and pathogenesis. While the elucidation of Wolbachia:nematode interactions that promote the bacterium's intracellular persistence is of great importance, research has been hampered due to the fact that Wolbachia cannot be cultured in the absence of host cells. The Wolbachia endosymbiont of B. malayi (wBm) has an active Type IV secretion system (T4SS). Here, we have screened 47 putative T4SS effector proteins of wBm for their ability to modulate growth or the cell biology of a typical eukaryotic cell, Saccharomyces cerevisiae. Five candidates strongly inhibited yeast growth upon expression, and 6 additional proteins showed toxicity in the presence of zinc and caffeine. Studies on the uptake of an endocytic vacuole-specific fluorescent marker, FM4-64, identified 4 proteins (wBm0076 wBm00114, wBm0447 and wBm0152) involved in vacuole membrane dynamics. The WAS(p)-family protein, wBm0076, was found to colocalize with yeast cortical actin patches and disrupted actin cytoskeleton dynamics upon expression. Deletion of the Arp2/3-activating protein, Abp1p, provided resistance to wBm0076 expression, suggesting a role for wBm0076 in regulating eukaryotic actin dynamics and cortical actin patch formation. Furthermore, wBm0152 was found to strongly disrupt endosome:vacuole cargo trafficking in yeast. This study provides molecular insight into the potential role of the T4SS in the Wolbachia endosymbiont:nematode relationship.

Indexed as

Bacterial ProteinsSymbiosisType IV Secretion SystemsWolbachiaAnimalsBrugia malayiGene Expression Regulation, BacterialSaccharomyces cerevisiaeBacterial ProteinsType IV Secretion Systems

Identifiers

PMID30261054
PMCPMC6160203
OpenAlexW2892846611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.